Clinical Trial Update: Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating adjunctive perampanel (E2007) for refractory partial seizures in epilepsy; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2016-01-26